Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Gan & Lee's Insulin Aspart Wins Ethiopian Registration – First Rapid‑Acting Insulin Analogue Approved in Africa's Second‑Most‑Populous Nation
CompanyDrug

Gan & Lee’s Insulin Aspart Wins Ethiopian Registration – First Rapid‑Acting Insulin Analogue Approved in Africa’s Second‑Most‑Populous Nation

Gan & Lee Pharmaceuticals Co., Ltd. (SHA: 603087) announced that it has received a drug registration certificate from the Ethiopian Food and Drug Authority (EFDA) for Rapilin (Insulin Aspart Injection,…

Humanwell Healthcare Subsidiary Wins FDA ANDA Approval for Diltiazem Hydrochloride Tablets – Expanding U.S. Generic Cardiovascular Portfolio

Humanwell Healthcare Subsidiary Wins FDA ANDA Approval for Diltiazem Hydrochloride Tablets – Expanding U.S. Generic Cardiovascular Portfolio

Zhongsheng Pharma's RAY1225 Achieves 22.2% Weight Loss in Phase III REBUILDING‑2 Trial – Biweekly GLP‑1/GIP Dual Agonist Outperforms Tirzepatide Response Rates on Key Thresholds

Zhongsheng Pharma’s RAY1225 Achieves 22.2% Weight Loss in Phase III REBUILDING‑2 Trial – Biweekly GLP‑1/GIP Dual Agonist Outperforms Tirzepatide Response Rates on Key Thresholds

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

AstraZeneca’s Tagrisso Secures FDA Approval for Unresectable Stage III EGFRm NSCLC

CompanyMedical Device

Sansure Biotech’s HPV Detection Kit Receives NMPA Approval for Comprehensive Screening

CompanyDrug

Sino Biopharmaceutical Receives NMPA Approval for Rivastigmine Patch for Mild-to-Moderate Alzheimer’s

CompanyDrug

Shanghai Haihe Pharmaceutical’s Oral Paclitaxel RMX3001 Wins NMPA Nod for Advanced Gastric Cancer

CompanyDrug

Eli Lilly’s Kisunla Secures Market Approval in Japan for Early Symptomatic Alzheimer’s

CompanyDrug

Amgen’s Tepezza Receives Approval in Japan for Treating Thyroid Eye Disease

CompanyDrug

Junshi Biosciences’ Toripalimab Secures EC Nod for Two Cancer Indications

CompanyMedical Device

Huadong Medicine’s V20 Device Receives NMPA Approval for Market Launch

Show More